In primary and secondary brain tumors, a negative correlation has been described between soluble PD-L1 and hsCRP, neutrophil counts, and other systemic inflammation markers such as CD3+ and CD8+ T cell counts [72]. Here, CD8A is linked to brain neoplasm.